D59.9
Acquired hemolytic anemia, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Idiopathic hemolytic anemia, chronic
Medical Intelligence & Overview
Acquired hemolytic anemia is a condition where the body's immune system mistakenly destroys its own red blood cells faster than they can be replaced. This leads to a shortage of healthy red blood cells, resulting in symptoms like fatigue, weakness, and pale skin. The specific code D59.9 refers to an unspecified type of acquired hemolytic anemia, often termed idiopathic hemolytic anemia, chronic in nature. While the exact cause might not always be clear, understanding its features and management options can aid in better awareness of the condition.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, where the immune system attacks red blood cells Medications inducing hemolysis, such as certain antibiotics or other drugs Infections that trigger immune responses affecting blood cells Certain cancers or blood disorders Exposure to toxic chemicals or substances Genetic predispositions that may manifest later in life Idiopathic origin, meaning the cause remains unknown
Key Symptoms: Fatigue and weakness Pale or jaundiced skin (yellowish tint) Shortness of breath Rapid heartbeat Dark-colored urine Splenomegaly (enlarged spleen) Headaches Dizziness or lightheadedness Chills or fever, if related to an underlying infection
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests such as complete blood count (CBC), which can reveal anemia and red blood cell destruction. Additional tests like the Coombs test help identify immune-mediated hemolysis. A detailed medical history and physical examination are essential, focusing on symptoms and potential triggers. Sometimes, tests to rule out other causes of anemia or specific investigations for underlying conditions are necessary.
Treatment Protocols: Management strategies aim to reduce red blood cell destruction and treat symptoms. These may include corticosteroids to suppress immune activity or immunosuppressive medications in some cases. In severe instances, therapies like blood transfusions or removal of the spleen (splenectomy) might be considered. Addressing underlying causes, if identified, is crucial. Supportive care, such as folic acid supplements and adequate hydration, also plays a role. Ongoing monitoring helps adjust treatment plans according to disease progression.
Clinical Advice & FAQs
Billing Guidance
Is D59.9 a billable ICD-10 code?
Yes, D59.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D59.9?
Clinical documentation must specify the nature of Acquired hemolytic anemia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference